Table 9 Comparison of diabetes mellitus indicators before and after joining Family Health Networks by region

Eye Examination - 2 years

30-39

64.4

34.1*

66.8

35.3*

62.0

35.6*

61.4

28.5*

Male

59.4

34.6*

63.2

34.5*

58.6

36.7*

51.7

31.6*

Female

68.0

33.8*

69.3

35.9*

64.8

34.9*

68.8

26.5*

40-64

73.9

46.1*

74.4

45.8*

73.4

46.9*

73.6

45.6*

Male

71.5

45.2*

72.1

45.1*

71.5

46.6*

70.3

43.5*

Female

76.9

47.2*

77.2

46.6*

75.9

47.3*

77.5

48.0*

65-74

83.9

85.5*

84.4

85.6

82.6

85.9

84.5

84.8

Male

82.4

84.1

82.6

84.1

81.7

84.5

82.9

83.6

Female

85.6

87.1

86.5

87.3

83.7

87.6

86.3

86.3

75+

86.0

84.0

85.7

84.7

85.9

83.6

86.5

83.2

Male

85.2

85.6

84.1

85.8

86.0

86.9

86.3

83.9

Female

86.5

82.6

86.8

83.8

85.9

80.9

86.7

82.6

Overall

78.2

64.6*

78.4

63.4*

77.5

64.7*

78.5

65.7*

Male

76.0

63.6*

76.1

62.4*

74.0

64.3*

75.9

65.0*

Female

80.5

65.1*

80.8

64.4*

79.4

65.2*

81.3

66.5*

Metformin - 1 year

65-74

68.5

86.7*

64.8

86.6*

77.8

85.1*

66.2

88.2*

Male

77.0

84.3*

77.5

83.3

81.8

87.5

73.7

82.9

Female

61.2

89.5*

54.9

90.7*

75.0

82.9

57.6

96.3

75 and older

69.2

83.2*

66.1

82.8*

64.5

83.6*

80.0

83.3

Male

73.1

80.6*

69.2

71.4

75.0

88.0

78.6

81.3

Female

66.2

84.9*

63.3

88.4*

57.9

80.0

81.3

85.0

Overall

68.8

85.3*

65.3

85.1*

72.9

84.4*

70.3

86.5*

Male

75.7

83.1*

74.2

80.0

79.4

87.7

75.0

82.5

Female

63.0

87.4*

58.0

89.5*

68.6

81.5

65.3

91.5*

ACE inhibitor - 1 year

65-74

61.2

71.1*

61.1

70.9*

63.4

72.6*

59.0

69.7*

Male

62.0

71.7*

61.6

71.7*

64.4

73.6*

59.9

69.9*

Female

60.3

70.2*

60.5

70.0*

62.2

71.4

57.9

69.4*

75 and older

58.9

68.9*

58.5

69.5*

60.3

70.2*

58.0

66.5*

Male

57.4

69.1*

55.8

69.7*

61.1

71.8

55.8

65.2*

Female

60.0

68.8*

60.4

69.3*

59.8

68.9*

59.7

67.6

Overall

60.4

70.1*

60.1

70.3*

62.2

71.5*

58.6

68.4*

Male

60.5

70.7*

59.8

70.9*

63.4

72.9*

58.7

68.2*

Female

60.2

69.5*

60.5

69.7*

61.1

70.2*

58.6

68.5*

Antihypertensive agent - 1 year

65-74

64.9

68.0*

63.8

68.0*

68.1

69.2

63.0

66.7

Male

61.2

65.7*

60.9

66.4

64.5

67.1

58.2

63.3

Female

68.5

70.7*

66.7

69.8

71.5

71.7

68.0

71.1

75 and older

71.0

75.0*

69.0

74.5*

75.7

76.1

68.6

74.5

Male

67.4

72.2*

65.9

71.8

72.6

71.6

64.2

73.5

Female

73.6

77.3*

71.3

76.6*

77.9

79.7

72.1

75.5

Overall

64.9

71.1*

63.8

71.0*

68.1

72.2*

63.0

69.9*

Male

61.2

68.2*

60.9

68.6*

64.5

68.9*

58.2

67.0*

Female

68.5

73.9*

66.7

73.2*

71.5

75.6*

68.0

73.1

Lipid-lowering agent - 1 year

65-74

47.3

63.5*

50.5

67.2*

47.0

60.8*

42.9

60.6*

Male

47.8

64.8*

51.9

69.6*

46.3

61.9*

43.2

61.0*

Female

46.7

61.8*

48.8

64.4*

47.8

59.4*

42.5

60.2*

75 and older

38.5

53.2*

40.5

56.8

37.0

49.8*

36.7

50.6

Male

40.9

57.6*

41.3

59.5*

41.9

56.2*

39.2

55.9

Female

36.7

49.7*

39.9

54.8

33.7

44.7

34.7

46.0

Overall

44.1

58.9*

46.7

62.5*

43.2

55.9*

40.8

56.5*

Male

45.7

62.0*

48.5

65.5*

45.0

59.7*

42.0

59.1*

Female

42.5

55.9*

45.0

59.6*

41.5

52.1*

39.5

53.6*

All three - 1 year

65-74

25.7

39.5*

27.2

41.7*

26.4

39.1*

22.8

36.5*

Male

25.7

40.1*

27.9

42.8*

25.8

40.3*

22.3

36.2*

Female

25.7

38.7*

26.3

40.4*

27.1

37.8*

23.3

36.8*

75 and older

22.5

35.4*

23.9

37.8*

21.7

33.9*

21.0

33.0

Male

23.3

37.4*

22.1

38.0*

25.5

37.3*

22.8

36.5*

Female

21.9

33.8*

25.1

37.6*

19.1

31.1

19.5

29.9

Overall

24.5

37.7*

25.9

39.9*

24.6

36.8*

22.2

35.0

Male

24.9

39.1*

26.0

40.9*

25.7

39.1*

22.4

36.3*

Female

24.1

36.3*

25.8

39.0*

23.5

34.5*

21.9

33.6